Advertisement
Screener

Synergy CHC Corp. (SNYR) Revenues, Net of Interest Expense

1.4 / 5 stars · 10/35 Roast Me

Synergy CHC Corp. Revenues, Net of Interest Expense

Synergy CHC Corp. (SNYR) reported Revenues, Net of Interest Expense of $30.00 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.

Financial Statements › Expense Statement › Interest Expense

us-gaap:RevenuesNetOfInterestExpense · last filed 2025-05-15

  • Synergy CHC Corp. revenues, net of interest expense for the quarter ending 2025-03-31 was $30.00M.
  • Synergy CHC Corp. revenues, net of interest expense for the quarter ending 2024-12-31 was $0.00.
  • Synergy CHC Corp. revenues, net of interest expense for fiscal 2024 was $30.00M.
Period endRevenues, Net of Interest Expense 3 monthRevenues, Net of Interest Expense 6 monthRevenues, Net of Interest Expense 9 monthRevenues, Net of Interest Expense 12 month
2025-03-31$30.00M
10-Q · filed 2025-05-15
$30.00M
derived: sum of 2 quarters · filed 2025-05-15
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$30.00M
10-K · filed 2025-03-31
2024-09-30$30.00M
10-Q · filed 2024-12-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87